Search
for
Sort by
Research 31–60 of 1000+
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Janus Kinase inhibitors in dermatology: a review
- Multiple Roles of Integrin-Linked Kinase in Epidermal Development, Maturation and Pigmentation Revealed by Molecular Profiling
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Cell wall-associated ROOT HAIR SPECIFIC 10, a proline-rich receptor-like kinase, is a negative modulator of Arabidopsis root hair growth
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Salicylate induces epithelial actin reorganization via activation of the AMP-activated protein kinase and promotes wound healing and contraction in mice
- Purified Vitexin Compound 1 Inhibits UVA-Induced Cellular Senescence in Human Dermal Fibroblasts by Binding Mitogen-Activated Protein Kinase 1
- Various Wavelengths of Light-Emitting Diode Light Regulate the Proliferation of Human Dermal Papilla Cells and Hair Follicles via Wnt/β-Catenin and the Extracellular Signal-Regulated Kinase Pathways
- Valproate-Associated Transaminitis and Rhabdomyolysis
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- The Use of Janus Kinase Inhibitors for Primary Neutrophilic Cicatricial Alopecias
- Use of intramuscular triamcinolone acetonide in intermediate responders to janus kinase inhibition for alopecia areata: Case report
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Tofacitinib for the treatment of lichen planopilaris: A case series
- A novel therapeutic paradigm for patients with extensive alopecia areata
- A Case of Cicatricial Alopecia Associated with Erlotinib
- Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Janus kinase inhibitors for alopecia areata: A narrative review
- Topical tofacitinib in treatment of alopecia areata
- Hair Follicle Reconstruction and Stem Cells